GPX4-targeting therapy reduces epigenetic age markers and circulating inflammation, raising questions about effects beyond treated skin.
Link as first comment.
@longevitytech.bsky.social
@longevitytech.bsky.socialGPX4-targeting therapy reduces epigenetic age markers and circulating inflammation, raising questions about effects beyond treated skin.
Link as first comment.
@lozanzi.bsky.social#ToDieOrNotToDie, that is the question! For #FerroptosisLovers & more! Chu &co show @cp-cell.bsky.social that glutathione does more than protecting from ferroptosis via #GPX4 but it is also fundamental for #FSP1-mediated protection! www.cell.com/cell/abstrac...